US Patent Issued to Tuojie Biotech (Shanghai) on July 22 for "Anti-CD79B antibody, antigen-binding fragment thereof, and pharmaceutical use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,730, issued on July 22, was assigned to Tuojie Biotech (Shanghai) Co. Ltd. (Shanghai).

"Anti-CD79B antibody, antigen-binding fragment thereof, and pharmaceutical use thereof" was invented by Cuiqing Yang (Shanghai) and Renhong Tang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an anti-CD79B antibody, an antigen-binding fragment thereof, and a pharmaceutical use thereof. Furthermore, the present invention relates to a chimeric antibody and a humanized antibody comprising a CDR region of the anti-CD79B antibody, a pharmaceutical composition comprising the anti-CD79B antibody or the antigen-binding fragment t...